Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Grebenciucova

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Neurology and Neuroscience Reports|July 3, 2017
Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple SclerosisElena Grebenciucova, Joseph R Berger
Neurologic Clinics|October 28, 2018
Progressive Multifocal LeukoencephalopathyElena Grebenciucova, Joseph R Berger
Current Neurology and Neuroscience Reports|September 24, 2017
Infections in Patients Receiving Multiple Sclerosis Disease-Modifying TherapiesElena Grebenciucova, Amy Pruitt
Frontiers in Immunology|October 16, 2023
Interleukin 6: at the interface of human health and diseaseElena Grebenciucova, Stephen VanHaerents
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2023
Rituximab and pregnancy: Late-onset neutropenia in a 2-month infant whose mother received rituximab 2 weeks prior to childbirthNatalia Gonzalez Caldito, Edith L Graham, Elena Grebenciucova
Multiple Sclerosis and Related Disorders|December 7, 2016
Corrigendum to 'Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature' [Mult. Scler. Relat. Disord. 9 (2016) 158-162]Elena Grebenciucova, Anthony T Reder, Jacqueline T Bernard
Multiple Sclerosis and Related Disorders|September 21, 2016
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literatureElena Grebenciucova, Anthony T Reder, Jacqueline T Bernard
Therapeutics and Clinical Risk Management|July 26, 2014
Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challengesAndrea P Mann, Elena Grebenciucova, Rimas V Lukas
Frontiers in Neurology|July 24, 2023
Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated diseaseGina Perez-Giraldo, Natalia Gonzalez Caldito, Elena Grebenciucova
Annals of Neurology|September 20, 2020
Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 EraJohn R Ciotti, Elena Grebenciucova, Brandon P Moss, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Neurology and Neuroscience Reports|July 3, 2017
Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple SclerosisElena Grebenciucova, Joseph R Berger
Neurologic Clinics|October 28, 2018
Progressive Multifocal LeukoencephalopathyElena Grebenciucova, Joseph R Berger
Current Neurology and Neuroscience Reports|September 24, 2017
Infections in Patients Receiving Multiple Sclerosis Disease-Modifying TherapiesElena Grebenciucova, Amy Pruitt
Frontiers in Immunology|October 16, 2023
Interleukin 6: at the interface of human health and diseaseElena Grebenciucova, Stephen VanHaerents
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2023
Rituximab and pregnancy: Late-onset neutropenia in a 2-month infant whose mother received rituximab 2 weeks prior to childbirthNatalia Gonzalez Caldito, Edith L Graham, Elena Grebenciucova
Multiple Sclerosis and Related Disorders|December 7, 2016
Corrigendum to 'Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature' [Mult. Scler. Relat. Disord. 9 (2016) 158-162]Elena Grebenciucova, Anthony T Reder, Jacqueline T Bernard
Multiple Sclerosis and Related Disorders|September 21, 2016
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literatureElena Grebenciucova, Anthony T Reder, Jacqueline T Bernard
Therapeutics and Clinical Risk Management|July 26, 2014
Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challengesAndrea P Mann, Elena Grebenciucova, Rimas V Lukas
Frontiers in Neurology|July 24, 2023
Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated diseaseGina Perez-Giraldo, Natalia Gonzalez Caldito, Elena Grebenciucova
Annals of Neurology|September 20, 2020
Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 EraJohn R Ciotti, Elena Grebenciucova, Brandon P Moss, et al.
Pageof 2